Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chaumet

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
European Journal of Biochemistry|March 2, 1987
Phenobarbital-mediated modulation of gene expression in rat liver. Analysis of cDNA clonesM C Lechner, C Sinogas, M L Osório-Almeida, et al.
The Journal of Biological Chemistry|December 10, 1983
Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase BM P Simon, C Besmond, D Cottreau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostoneP Rozenberg, S Chevret, F Goffinet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Journal of Hepatology|August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 GroupF Degos, V Daurat, S Chevret, et al.
Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Biochemistry|March 2, 1987
Phenobarbital-mediated modulation of gene expression in rat liver. Analysis of cDNA clonesM C Lechner, C Sinogas, M L Osório-Almeida, et al.
The Journal of Biological Chemistry|December 10, 1983
Molecular cloning of cDNA for rat L-type pyruvate kinase and aldolase BM P Simon, C Besmond, D Cottreau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 15, 2002
Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal misoprostol and intravaginal dinoprostoneP Rozenberg, S Chevret, F Goffinet, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|August 1, 1991
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover studyH Allain, F Le Coz, F Goulley, et al.
Journal of Hepatology|August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 GroupF Degos, V Daurat, S Chevret, et al.
Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.
Therapie|March 10, 2001
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)]P Lechat, H Lardoux, A Mallet, et al.
Cerebrovascular Diseases (Basel, Switzerland)|October 20, 2001
Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS)P Lechat, H Lardoux, A Mallet, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Pageof 3